The European Union research and innovation ecosystem is at a turning point. While the Letta, Draghi & Heitor reports emphasised the instrumental role played by research and innovation in driving forward Europe’s leadership in life sciences and its overall competitiveness, challenges are mounting including strained budgets, a strongly competitive funding environment, increasing bureaucratic burdens [...]

On March 11, the European Commission presented the much-anticipated Critical Medicines Act, a proposal aimed at strengthening the resilience and autonomy of the EU’s pharmaceutical supply chain. The European Brain Council (EBC) welcomes this initiative as an important step toward a stronger, more innovative, and competitive Health Union, particularly in light of increased geopolitical [...]